Sintilimab Combined With Regorafenib and HAIC in Patients With Colorectal Liver Metastasis

ABSTRACT: To evaluate the safety and efficacy of sintilimab combined with regorafenib and HAIC in patients with colorectal liver metastasis who failed second-line therapy

DISEASE(S): Neoplasm Metastasis,Colorectal Cancer,Liver Metastasis,Liver Neoplasms

PROVIDER: 2747042 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR